Efficient gene delivery and expression in mammalian cells using DNA coupled with perfringolysin O

Area of Science:

• Molecular Biology
• Biochemistry
• Gene Therapy

Background:

• Non-viral DNA vectors for gene therapy face challenges with low cellular transfection efficiency and gene expression.
• Inefficient endosomal DNA release is a key limitation in current gene delivery systems.

Purpose of the Study:

• To investigate the potential of perfringolysin O (PFO), a membrane-active bacterial protein, as a non-viral DNA delivery vehicle for gene therapy.
• To assess the efficiency of DNA-PFO complexes in achieving high gene expression in cells.

Main Methods:

• Incorporation of perfringolysin O (PFO) into DNA complexes using a biotin-streptavidin bridge.
• Delivery of the Escherichia coli beta-galactosidase gene into murine sol 8 myoblast cells using DNA-PFO complexes.
• Quantification of gene expression via X-gal staining.

Main Results:

• High levels of gene expression were achieved in murine sol 8 myoblast cells using DNA-PFO complexes.
• Gene expression levels demonstrated a positive correlation with the PFO content within the complexes.
• Optimal conditions resulted in 15-20% of cells exhibiting blue staining (indicating gene expression), independent of receptor ligands.

Conclusions:

• Membrane-active bacterial proteins, such as PFO, represent a promising strategy for developing effective non-viral DNA delivery systems.
• The DNA-PFO complex system offers a viable alternative to overcome limitations in current gene therapy vectors.
• This approach holds potential for advancing non-viral gene delivery for therapeutic applications.